Sudha Seshadri, MD
Director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases
Dr. Seshadri is a senior investigator of the Framingham Heart Study since 1998, leading the study’s clinical neurology and neurogenesis cores since 2005. She is the principal investigator on 8 NIH funded grants and is an investigator, subcontract principal investigator and consultant to 12 additional grants.
She has served on the Editorial Board for Neurology and Stroke, chaired a standing NIH Study Section (Neurology, Aging and Musculoskeletal Epidemiology) and has over 320 peer-reviewed publications (H-index 79, i10 index 209), including 57 in 2016.
Dr. Seshadri helped to establish the neurology phenotype working group within the Cohorts for Heart and Aging Research in Genomic Epidemiology (CHARGE) consortium.
She lectures extensively, nationally and internationally, on Alzheimer’s disease, dementia and the genetics of stroke and vascular brain injury.
View research profile
The New York Times: Prolonged Sleep may be Early Warning Sign of Dementia
Sudha Seshadri, MD, comments on the link between sleep and early cognitive decline.
TIME Magazine: Stressed-Out People May Have Smaller Brains, Study Says
Study co-author, Sudha Seshadri, MD, comments on how the effects from stress could be a precursor to cognitive decline later in life.
CNN: Genetic predisposition toward higher blood pressure, cholesterol may be linked to Alzheimer’s risk, study finds
Sudha Seshadri, MD, was interviewed by CNN on a research study showing certain forms of higher blood pressure and cholesterol with a genetic link could be related to an increased risk of developing Alzheimer’s disease.